Versuchen GOLD - Frei
The Fed is increasingly torn over a December rate cut
Mint Hyderabad
|November 13, 2025
The path for interest-rate cuts has been clouded by an emerging split within the central bank with little precedent during Federal Reserve Chair Jerome Powell's nearly eight-year tenure.
Cutting rates at three consecutive meetings would echo the downward adjustments Federal Reserve Chair Jerome Powell made last year and in 2019.
(REUTERS)
Officials are fractured over which poses the greater threat—persistent inflation or a sluggish labor market—and even a resumption of official economic data may not bridge the differences.
The rupture has complicated what looked like a workable plan less than two months ago, though investors think a rate cut at the Fed’s next meeting is still more likely than not.
When policymakers agreed to cut rates by a quarter of a percentage point in September, 10 of 19 officials, a slim majority, penciled in cuts for October and December. Cutting rates at three consecutive meetings would echo the downward adjustments Powell made last year and in 2019.
But a contingent of hawks questioned the need for further reductions. Their resistance hardened after officials reduced rates again in late October to the current range between 3.75% and 4%. The debate over what to do in December was especially contentious, with hawks forcefully challenging the presumption of a third cut, according to public comments and recent interviews.
Indeed, a key reason Powell pushed back so bluntly against expectations of such a cut at the press conference that day was to manage a committee riven by seemingly unbridgeable differences.
The split was exacerbated by the government shutdown, which turned off the employment and inflation reports that can help reconcile such disagreements. The data void allowed officials to cite private surveys or anecdotes that reinforced earlier assessments.
The dynamic reflected two contingents growing louder and a center with less conviction. Doves worried about labor-market softness but lacked new evidence that would maintain a strong case for cutting.
Diese Geschichte stammt aus der November 13, 2025-Ausgabe von Mint Hyderabad.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Hyderabad
Mint Hyderabad
Nvidia, Eli Lilly to invest $1 bn in AI lab
Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence (AI) in the pharmaceutical industry.
1 min
January 13, 2026
Mint Hyderabad
Shadowfax IPO to open next week
Logistics services provider Shadowfax is set to launch its ₹1,900-crore initial public offering (IPO) next week, targeting a valuation of ₹7,400 crore, people familiar with the matter said on Monday.
1 min
January 13, 2026
Mint Hyderabad
The US climate cop-out should galvanize others
America's withdrawal from the global battle against climate change is a signal for the rest of the world to unite for the greater good. The cause is vital, not the participation of the US
2 mins
January 13, 2026
Mint Hyderabad
Toyota pushes for fuel norm clarity
The government should soon come out with the final notification for the next phase of India’s Corporate Average Fuel Efficiency standards so that the industry can prepare accordingly, according to a senior Toyota Kirloskar Motor executive.
1 min
January 13, 2026
Mint Hyderabad
Food effect lifts Dec CPI inflation
India's retail inflation rose for the second successive month in December, data released by the statistics ministry on Monday showed, driven by a moderation in negative food inflation and an uptick in core inflation.
1 min
January 13, 2026
Mint Hyderabad
Commissions trump advice in wealth management biz
surge on rising affluence, strong economic growth, higher foreign direct investments, and the growth of the startup ecosystem.
2 mins
January 13, 2026
Mint Hyderabad
The Chinese company taking on the world's memory-chip giants
As AI demand drives prices up, CXMT beats Washington's curbs to vie with Micron and South Korean leaders
4 mins
January 13, 2026
Mint Hyderabad
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Hyderabad
Fix GST on capital goods to revive private investment
India faces a paradox today.
3 mins
January 13, 2026
Mint Hyderabad
Feeling tired? It could be too many messages
The cumulative stress of constant notifications is leaving many emotionally burnt out. Tackling it requires small, sustainable changes
4 mins
January 13, 2026
Listen
Translate
Change font size
